跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
JELIDO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
JELIDO
Authorized
STANDARD
JELIDO
pendopharm division of pharmascience inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9d41e6623212bc76
Company
pendopharm division of pharmascience inc
Type
Standard
Approval Details
Approval Id
9d41e6623212bc76
Drug Approval Canada Name
JELIDO
Product Name
JELIDO
Status
Marketed
Status Date
2018-05-28
Original Market Date
2018-05-28
Din
02469146
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
Ethical
Ahfs
72:00.00
Atc Original
N01BB02 LIDOCAINE
Atc Name
n 01 bb 02
Aig Number
0101280001
Company Name
pendopharm division of pharmascience inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Active Ingredients
LIDOCAINE HYDROCHLORIDE
20 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9d41e6623212bc76
Type
Standard
Back to Health Canada Approvals